Jenny Sundqvist
Chief Executive Officer bei INDEX PHARMACEUTICALS HOLDING AB
Profil
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Aktive Positionen von Jenny Sundqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01.01.2023 |
Ehemalige bekannte Positionen von Jenny Sundqvist
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.04.2021 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Ausbildung von Jenny Sundqvist
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
